Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
October-2019 Volume 42 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2019 Volume 42 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article

Homophilic complex formation of CDCP1 via the extracellular CUB2 domain facilitates SFK activation and promotes cancer cell migration

  • Authors:
    • Tadashi Sawayama
    • Katsuhiko Nakashima
    • Tohru Ichimura
    • Ryuichi Sakai
    • Takamasa Uekita
  • View Affiliations / Copyright

    Affiliations: Department of Applied Chemistry, National Defense Academy, Yokosuka 23908686, Japan, Division of Refractory and Advanced Cancer, National Cancer Center Research Institute, Tokyo 105‑0045, Japan
  • Pages: 1507-1516
    |
    Published online on: August 8, 2019
       https://doi.org/10.3892/or.2019.7271
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

CUB domain‑containing protein 1 (CDCP1) is phosphorylated by Src family kinases (SFK), and is thought to serve an important role in tumor metastasis through downstream signaling subsequent to its interaction with protein kinase C δ. The present study investigated the mechanisms of activation for CDCP1 signaling, and demonstrated that CDCP1 is able to activate SFK via a homophilic complex of the extracellular complement C1r/C1s, urchin embryonic growth factor, bone morphogenetic protein 1 (CUB) 2 domain. Deletion of the extracellular CDCP1 region abolished homophilic complex formation of CDCP1 and the ability to promote cancer cell migration. When the culture medium was supplemented with recombinant CUB2 domain protein fused with maltose binding protein (rMBP‑CUB2), CDCP1 homophilic complex formation was effectively inhibited. rMBP‑CUB2 also inhibited SFK activation and the migratory capacity of invasive human lung adenocarcinoma A549 cells, and human pancreatic BxPC3 cells. These findings demonstrated a novel function for the extracellular CUB2 domain of CDCP1, promoting cancer cell migration via SFK activation on the plasma membrane. It was also indicated that the region blocking the homophilic binding site may be a potential therapeutic target against CDCP1‑dependent tumor invasion.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Hu G, Place AT and Minshall RD: Regulation of endothelial permeability by Src kinase signaling: Vascular leakage versus transcellular transport of drugs and macromolecules. Chem Biol Interact. 171:177–189. 2010. View Article : Google Scholar

2 

Brown MT and Cooper JA: Regulation, substrates and functions of src. Biochim Biophy Acta. 1287:121–149. 1996.

3 

Irby RB and Yeatman TJ: Role of Src expression and activation in human cancer. Oncogene. 19:5636–5642. 2000. View Article : Google Scholar : PubMed/NCBI

4 

Summy JM and Gallick GE: Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev. 22:337–358. 2003. View Article : Google Scholar : PubMed/NCBI

5 

Hooper JD, Zijlstra A, Aimes RT, Liang H, Claassen GF, Tarin D, Testa JE and Quigley JP: Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen. Oncogene. 22:1783–1794. 2003. View Article : Google Scholar : PubMed/NCBI

6 

Brown TA, Yang TM, Zaitsevskaia T, Xia Y, Dunn CA, Sigle RO, Knudsen B and Carter WG: Adhesion or plasmin regulates tyrosine phosphorylation of a novel membrane glycoprotein p80/gp140/CUB domain-containing protein 1 in epithelia. J Biol Chem. 279:14772–14783. 2004. View Article : Google Scholar : PubMed/NCBI

7 

Bhatt AS, Erdjument-Bromage H, Tempst P, Craik CS and Moasser MM: Adhesion signaling by a novel mitotic substrate of src kinase. Oncogene. 24:5333–5343. 2005. View Article : Google Scholar : PubMed/NCBI

8 

Scherl-Mostageer M, Sommergruber W, Abseher R, Hauptmann R, Ambros P and Schweifer N: Identification of a novel gene, CDCP1, overexpressed in human colorectal cancer. Oncogene. 20:4402–4408. 2001. View Article : Google Scholar : PubMed/NCBI

9 

Uekita T, Jia L, Narisawa-Saito M, Yokota J, Kiyono T and Sakai R: CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma. Mol Cell Biol. 27:7649–7660. 2007. View Article : Google Scholar : PubMed/NCBI

10 

Benes CH, Wu N, Elia AE, Dharia T, Cantley LC and Soltoff SP: The C2 domain of PKCdelta is a phosphotyrosine binding domain. Cell. 121:271–280. 2005. View Article : Google Scholar : PubMed/NCBI

11 

Wortmann A, He Y, Christensen ME, Linn M, Lumley JW, Pollock PM, Waterhouse NJ and Hooper JD: Cellular settings mediating Src Substrates switching between focal adhesion kinase tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) tyrosine 734. J Biol Chem. 286:42303–42315. 2011. View Article : Google Scholar : PubMed/NCBI

12 

Dong Y, He Y, de Boer L, Stack MS, Lumley JW, Clements JA and Hooper JD: The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration. J Biol Chem. 287:9792–9803. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Miyazawa Y, Uekita T, Hiraoka N, Fujii S, Kosuge T, Kanai Y, Nojima Y and Sakai R: CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation. Cancer Res. 70:5136–5146. 2010. View Article : Google Scholar : PubMed/NCBI

14 

Uekita T and Sakai R: Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis. Cancer Sci. 102:1943–1948. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Bork P and Beckmann G: The CUB domain. A widespread module in developmentally regulated proteins. J Mol Biol. 231:539–545. 1993. View Article : Google Scholar : PubMed/NCBI

16 

Lee HX, Mendes FA, Plouhinec JL and De Robertis EM: Enzymatic regulation of pattern: BMP4 binds CUB domains of Tolloids and inhibits proteinase activity. Genes Dev. 23:2551–2562. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Romero A, Varela PF, Sanz L, Töpfer-Petersen E and Calvete JJ: Crystallization and preliminary X-ray diffraction analysis of boar seminal plasma spermadhesin PSP-I/PSP-II, a heterodimer of two CUB domains. FEBS Lett. 382:15–17. 1996. View Article : Google Scholar : PubMed/NCBI

18 

Wright HJ, Arulmoli J, Motazedi M, Nelson LJ, Heinemann FS, Flanagan LA and Razorenova OV: CDCP1 cleavage is necessary for homodimerization-induced migration of triple-negative breast cancer. Oncogene. 35:4762–4772. 2016. View Article : Google Scholar : PubMed/NCBI

19 

Yang L, Dutta SM, Troyer DA, Lin JB, Lance RA, Nyalwidhe JO, Drake RR and Semmes OJ: Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer. Oncotarget. 6:43743–43758. 2015. View Article : Google Scholar : PubMed/NCBI

20 

Kollmorgen G, Bossenmaier B, Niederfellner G, Häring HU and Lammers R: Structual requirements for cub domain containing protein 1 (CDCP1) and Src dependent cell transformation. PLoS One. 7:e530502012. View Article : Google Scholar : PubMed/NCBI

21 

Casar B, He Y, Iconomou M, Hooper JD, Quigley JP and Deryugina EI: Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-medited apoptosis of cancer cells. Oncogene. 31:3924–3938. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Burnham MR, Bruce-Staskal PJ, Harte MT, Weidow CL, Ma A, Weed SA and Bouton AH: Regulation of c-SRC activity and function by the adapter protein CAS. Mol Cell Biol. 20:5865–5878. 2000. View Article : Google Scholar : PubMed/NCBI

23 

Tanaka M, Sasaki K, Kamata R, Hoshino Y, Yanagihara K and Sakai R: A novel RNA-binding protein, Ossa/C9orf10, regulates activity of Src kinase to protect cells from oxidative stress-induced apoptosis. Mol Cell Biol. 22:402–413. 2009. View Article : Google Scholar

24 

Liu H, Ong SE, Badu-Nkansah K, Schindler J, White FM and Hynes RO: CUB-domain-containing protein 1 (CDCP1) activates Src to promotes melanoma metastasis. Proc Natl Acad Sci USA. 108:1379–1384. 2011. View Article : Google Scholar : PubMed/NCBI

25 

Xia Y, Gil SG and Carter WG: Anchorage mediated by integrin alpha6beta4 to laminin 5 (epiligrin) regulates tyrosine phosphorylation of a membrane-associated 80-kD protein. J Cell Biol. 134:724–740. 1996.

26 

Miura S, Hamada S, Masamune A, Satoh K and Shimosegawa T: CUB-domain containing protein 1 represses the epithelial phenotype of pancreatic cancer cell. Exp Cell Res. 321:209–218. 2014. View Article : Google Scholar : PubMed/NCBI

27 

Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T and Seiki M: Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J. 20:4782–4793. 2001. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Sawayama T, Nakashima K, Ichimura T, Sakai R and Uekita T: Homophilic complex formation of CDCP1 via the extracellular CUB2 domain facilitates SFK activation and promotes cancer cell migration . Oncol Rep 42: 1507-1516, 2019.
APA
Sawayama, T., Nakashima, K., Ichimura, T., Sakai, R., & Uekita, T. (2019). Homophilic complex formation of CDCP1 via the extracellular CUB2 domain facilitates SFK activation and promotes cancer cell migration . Oncology Reports, 42, 1507-1516. https://doi.org/10.3892/or.2019.7271
MLA
Sawayama, T., Nakashima, K., Ichimura, T., Sakai, R., Uekita, T."Homophilic complex formation of CDCP1 via the extracellular CUB2 domain facilitates SFK activation and promotes cancer cell migration ". Oncology Reports 42.4 (2019): 1507-1516.
Chicago
Sawayama, T., Nakashima, K., Ichimura, T., Sakai, R., Uekita, T."Homophilic complex formation of CDCP1 via the extracellular CUB2 domain facilitates SFK activation and promotes cancer cell migration ". Oncology Reports 42, no. 4 (2019): 1507-1516. https://doi.org/10.3892/or.2019.7271
Copy and paste a formatted citation
x
Spandidos Publications style
Sawayama T, Nakashima K, Ichimura T, Sakai R and Uekita T: Homophilic complex formation of CDCP1 via the extracellular CUB2 domain facilitates SFK activation and promotes cancer cell migration . Oncol Rep 42: 1507-1516, 2019.
APA
Sawayama, T., Nakashima, K., Ichimura, T., Sakai, R., & Uekita, T. (2019). Homophilic complex formation of CDCP1 via the extracellular CUB2 domain facilitates SFK activation and promotes cancer cell migration . Oncology Reports, 42, 1507-1516. https://doi.org/10.3892/or.2019.7271
MLA
Sawayama, T., Nakashima, K., Ichimura, T., Sakai, R., Uekita, T."Homophilic complex formation of CDCP1 via the extracellular CUB2 domain facilitates SFK activation and promotes cancer cell migration ". Oncology Reports 42.4 (2019): 1507-1516.
Chicago
Sawayama, T., Nakashima, K., Ichimura, T., Sakai, R., Uekita, T."Homophilic complex formation of CDCP1 via the extracellular CUB2 domain facilitates SFK activation and promotes cancer cell migration ". Oncology Reports 42, no. 4 (2019): 1507-1516. https://doi.org/10.3892/or.2019.7271
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team